Cargando…

Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial

BACKGROUND: New antimalarials are needed for P. vivax and P. falciparum malaria. This study compared the efficacy and safety of pyronaridine-artesunate with that of chloroquine for the treatment of uncomplicated P. vivax malaria. METHODS AND FINDINGS: This phase III randomized, double-blind, non-inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poravuth, Yi, Socheat, Duong, Rueangweerayut, Ronnatrai, Uthaisin, Chirapong, Pyae Phyo, Aung, Valecha, Neena, Rao, B. H. Krishnamoorthy, Tjitra, Emiliana, Purnama, Asep, Borghini-Fuhrer, Isabelle, Duparc, Stephan, Shin, Chang-Sik, Fleckenstein, Lawrence
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022577/ https://www.ncbi.nlm.nih.gov/pubmed/21267072 http://dx.doi.org/10.1371/journal.pone.0014501

Ejemplares similares

Pharmacokinetic Interaction between Pyronaridine-Artesunate and Metoprolol
por: Morris, Carrie A., et al.
Publicado: (2014)

Drug-Drug Interaction Analysis of Pyronaridine/Artesunate and Ritonavir in Healthy Volunteers
por: Morris, Carrie A., et al.
Publicado: (2012)

Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials
por: Duparc, Stephan, et al.
Publicado: (2013)

Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
por: Ayyoub, Amal, et al.
Publicado: (2016)

Efficacy and Safety of Pyronaridine–Artesunate for the Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax Malaria in Myanmar
por: Han, Kay Thwe, et al.
Publicado: (2020)

Review of pyronaridine anti-malarial properties and product characteristics
por: Croft, Simon L, et al.
Publicado: (2012)

Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial
por: Dabira, Edgard D, et al.
Publicado: (2021)

An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
por: Valecha, Neena, et al.
Publicado: (2010)

Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial
por: Kayentao, Kassoum, et al.
Publicado: (2012)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
por: Valecha, Neena, et al.
Publicado: (2010)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
por: Valecha, Neena, et al.
Publicado: (2010)

Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
por: Morris, Carrie A, et al.
Publicado: (2011)

Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
por: Sagara, Issaka, et al.
Publicado: (2016)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2019)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2022)

Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial
por: Groger, Mirjam, et al.
Publicado: (2022)

Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
por: Bukirwa, Hasifa, et al.
Publicado: (2014)

Pyronaridine–artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study
por: Tona Lutete, Gaston, et al.
Publicado: (2021)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults
por: Rattanapunya, Siwalee, et al.
Publicado: (2015)

Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
por: Jittamala, Podjanee, et al.
Publicado: (2014)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
por: Roth, Johanna M., et al.
Publicado: (2018)

Efficacy and safety of pyronaridine-artesunate (Pyramax(®)) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia
por: Mohammed, Hussein, et al.
Publicado: (2022)

Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria
por: Das, Debashish, et al.
Publicado: (2013)

Application of Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung and Trachea Exposure of Pyronaridine and Artesunate in Hamsters
por: Kang, Dong Wook, et al.
Publicado: (2023)

Therapeutic efficacy of pyronaridine-artesunate (Pyramax(®)) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia
por: Alebachew, Mihreteab, et al.
Publicado: (2023)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

The Efficacy of Artesunate, Chloroquine, Doxycycline, Primaquine and a Combination of Artesunate and Primaquine against Avian Malaria in Broilers
por: SOHSUEBNGARM, Damnern, et al.
Publicado: (2014)

Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?
por: Uzun, Tuğçenur, et al.
Publicado: (2020)

Pyronaridine–artesunate and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial
por: Roth, Johanna M., et al.
Publicado: (2018)

Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India
por: Savargaonkar, Deepali, et al.
Publicado: (2020)

Establishment and application of a novel isothermal amplification assay for rapid detection of chloroquine resistance (K76T) in Plasmodium falciparum
por: Chahar, Madhvi, et al.
Publicado: (2017)

Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria
por: Jullien, Vincent, et al.
Publicado: (2014)

A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia
por: Pasaribu, Ayodhia Pitaloka, et al.
Publicado: (2013)

Efficacy and safety of pyronaridine–artesunate versus artemether–lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial
por: Falade, Catherine O., et al.
Publicado: (2023)

Optimal dose finding for novel antimalarial combination therapy*
por: Duparc, S, et al.
Publicado: (2012)

Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
por: Price, Ric N, et al.
Publicado: (2014)

Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India
por: Mishra, Neelima, et al.
Publicado: (2014)

A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India
por: Srivastava, Prakriti, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ag1r23jqbtf0b7rfbfn29moiiv